Abbrea Capital, LLC Stryker Corp Transaction History

Abbrea Capital, LLC

$755 Million
Q2 2024

A detailed history of Abbrea Capital, LLC transactions in Stryker Corp stock. As of the latest transaction made, Abbrea Capital, LLC holds 7,950 shares of SYK stock, worth $2.85 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

7,950

Previous 8,007 0.71%

Holding current value

$2.85 Million

Previous $2.87 Million 5.61%

% of portfolio

0.36%

Previous 0.38%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$324.3 - $354.67 $18,485 - $20,216	-57 Reduced 0.71%	7,950 $2.71 Million
Q4 2023 Feb 02, 2024	BUY	$253.85 - $299.46 $15,231 - $17,967	60 Added 0.76%	8,007 $2.4 Million
Q3 2023 Oct 31, 2023	BUY	$266.54 - $302.43 $16,525 - $18,750	62 Added 0.79%	7,947 $2.18 Million
Q2 2023 Aug 01, 2023	BUY	$271.49 - $305.09 $9,502 - $10,678	35 Added 0.45%	7,885 $2.41 Million
Q4 2022 Feb 08, 2023	SELL	$205.51 - $253.93 $10,275 - $12,696	-50 Reduced 0.63%	7,850 $1.92 Million
Q3 2022 Nov 03, 2022	SELL	$189.27 - $231.83 $25,172 - $30,833	-133 Reduced 1.66%	7,900 $1.61 Million
Q2 2022 Aug 02, 2022	SELL	$194.09 - $276.37 $8,734 - $12,436	-45 Reduced 0.56%	8,033 $1.6 Million
Q1 2022 May 11, 2022	BUY	$245.33 - $277.77 $14,719 - $16,666	60 Added 0.75%	8,078 $2.17 Million
Q4 2021 Feb 04, 2022	BUY	$236.63 - $276.44 $42,830 - $50,035	181 Added 2.31%	8,018 $2.15 Million
Q3 2021 Nov 04, 2021	BUY	$248.9 - $280.09 $22,401 - $25,208	90 Added 1.16%	7,837 $2.07 Million
Q2 2021 Aug 04, 2021	BUY	$242.95 - $267.0 $58,793 - $64,614	242 Added 3.22%	7,747 $2.02 Million
Q1 2021 May 13, 2021	SELL	$221.01 - $248.82 $12,155 - $13,685	-55 Reduced 0.73%	7,505 $1.84 Million
Q4 2020 Jan 21, 2021	BUY	$202.01 - $245.04 $65,653 - $79,638	325 Added 4.49%	7,560 $1.86 Million
Q3 2020 Oct 20, 2020	SELL	$177.77 - $215.81 $16,888 - $20,501	-95 Reduced 1.3%	7,235 $1.51 Million
Q2 2020 Aug 11, 2020	SELL	$144.67 - $207.03 $96,639 - $138,296	-668 Reduced 8.35%	7,330 $1.33 Million
Q1 2020 Apr 29, 2020	BUY	$126.5 - $225.1 $10,752 - $19,133	85 Added 1.07%	7,998 $1.34 Million
Q4 2019 Feb 11, 2020	SELL	$197.98 - $220.53 $148,880 - $165,838	-752 Reduced 8.68%	7,913 $1.67 Million
Q3 2019 Nov 07, 2019	BUY	$205.4 - $221.82 $6,162 - $6,654	30 Added 0.35%	8,665 $1.88 Million
Q2 2019 Jul 31, 2019	BUY	$180.24 - $205.58 $32,443 - $37,004	180 Added 2.13%	8,635 $1.78 Million
Q3 2018 Nov 09, 2018	SELL	$163.25 - $177.68 $32,650 - $35,536	-200 Reduced 2.31%	8,455 $1.51 Million
Q1 2018 May 10, 2018	BUY	$148.01 - $168.91 $740 - $844	5 Added 0.06%	8,655 $1.4 Million
Q4 2017 Feb 01, 2018	SELL	$143.51 - $159.74 $16,503 - $18,370	-115 Reduced 1.31%	8,650 $1.34 Million
Q3 2017 Nov 07, 2017	BUY	$138.36 - $147.87 $1.21 Million - $1.3 Million	8,765	8,765 $1.25 Million

Others Institutions Holding SYK

# of Institutions

2,231

Shares Held

284M

Call Options Held

1.35M

Put Options Held

1.6M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbrea Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abbrea Capital, LLC with notifications on news.

Account

Abbrea Capital, LLC Stryker Corp Transaction History